Bookmark

Add to MyYahoo RSS

PDL BioPharma News

News on PDL BioPharma (Ticker: PDLI) continually updated from thousands of sources around the net.

Wednesday | AmericanBankingNews.com

PDL BioPharma Given New $8.00 Price Target at Cowen and Company

Cowen and Company's price objective points to a potential downside of 16.23% from the stock's previous close.

Comment?

Related Topix: Startups

Tue Aug 19, 2014

Seeking Alpha

PDL BioPharma's (PDLI) CEO John McLaughlin on Q2 2014 Results - Earnings Call Transcript

Good afternoon and welcome to the PDL BioPharma's Second Quarter 2014 Earnings Conference Call.

Comment?

Related Topix: Startups, Securities and Exchange Commission, Corporate / Securities Law, Law

Mon Aug 18, 2014

Hispanic Business

PDL Biopharma, Inc. - 10-Q - Management's Discussion and Analysis of...

This Quarterly Report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

Comment?

Related Topix: Startups, Corporate / Securities Law, Law

AmericanBankingNews.com

PDL BioPharma (PDLI) Posts Quarterly Earnings, Beats Estimates By $0.06 EPS

PDL BioPharma issued its quarterly earnings data on Monday. The company reported $0.52 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.46 by $0.06, AmericanBankingNews.com reports.

Comment?

Related Topix: Startups

Sys-Con Media

PDL BioPharma Announces Plans to Issue Second Quarter Financial...

The conference ID is 79689642. Please dial in approximately 10 minutes prior to the start of the call.

Comment?

Related Topix: Startups

Tue Aug 12, 2014

AmericanBankingNews.com

PDL BioPharma Sees Large Growth in Short Interest

PDL BioPharma was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totalling 33,322,431 shares, a growth of 5.3% from the July 15th total of 31,658,977 shares, AnalystRatings.NET reports.

Comment?

Related Topix: Startups

Mon Aug 11, 2014

BioSpace

Sorrento Therapeutics, Inc. Appoints To Its Board Of Directors

Currently, Mr. Ebersole is an independent consultant and has worked primarily with PDL BioPharma since 2005.

Comment?

Related Topix: Oncology, Medicine, Banking, Financial Services, Silicon Valley Bancshares, Startups

Hispanic Business

PDL Biopharma, Inc. Files (8-K) Disclosing Other Events

The Borrower Notice accelerates all obligations under the Company's credit agreement with Borrower and demands immediate payment in full in an amount equal to , the Company delivered a notice to each of the guarantors of Borrower's obligations to the Company under the credit agreement .

Comment?

Related Topix: Startups

BioSpace

PDL BioPharma, Inc. Announces Delay In Filing Quarterly Report On Form 10-Q

As previously disclosed, PDL was asked by the SEC to support its position and explain why this transaction was accounted for as the acquisition of intangible assets as opposed to that of financial assets.

Comment?

Related Topix: Startups, Securities and Exchange Commission, Corporate / Securities Law, Law, US Securities and Exchange Commission, Financial Services

Fri Aug 08, 2014

Sys-Con Media

Sorrento Therapeutics Appoints Douglas Ebersole to its Board of Directors

Currently, Mr. Ebersole is an independent consultant and has worked primarily with PDL BioPharma since 2005.

Comment?

Related Topix: Oncology, Medicine, Banking, Financial Services, Silicon Valley Bancshares, Startups

Sys-Con Media

PDL BioPharma Announces Delay in Filing Quarterly Report on Form 10-Q

As previously disclosed, PDL was asked by the SEC to support its position and explain why this transaction was accounted for as the acquisition of intangible assets as opposed to that of financial assets.

Comment?

Related Topix: Startups, Securities and Exchange Commission, Corporate / Securities Law, Law, US Securities and Exchange Commission, Financial Services

AmericanBankingNews.com

PDL BioPharma (PDLI) Scheduled to Post Earnings on Monday

PDL BioPharma is set to issue its Q214 quarterly earnings data on Monday, August 11th.

Comment?

Related Topix: Startups

Wed Jul 30, 2014

BioSpace

PDL BioPharma, Inc. To Participate In Jefferies and Co. 2014 Boston Healthcare Summit

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue.

Comment?

Related Topix: Startups

Mon Jul 28, 2014

Freshnews

PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014

PDL BioPharma, Inc. today announced that the Company will release its second quarter 2014 financial results for the period ended June 30, 2014, on Monday, August 11, 2014, after market close.

Comment?

Related Topix: Startups

Wed Jul 23, 2014

EurekAlert!

Protein evolution follows a modular principle

At first glance, proteins that fold into a barrel-like shape and proteins that fold into a sandwich-like shape appear completely different.

Comment?

Related Topix: Startups

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••